000 | 01911 a2200517 4500 | ||
---|---|---|---|
005 | 20250515092905.0 | ||
264 | 0 | _c20080219 | |
008 | 200802s 0 0 eng d | ||
022 | _a1097-4652 | ||
024 | 7 |
_a10.1002/jcp.21303 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChen, Chun-Lin | |
245 | 0 | 0 |
_aCholesterol modulates cellular TGF-beta responsiveness by altering TGF-beta binding to TGF-beta receptors. _h[electronic resource] |
260 |
_bJournal of cellular physiology _cApr 2008 |
||
300 |
_a223-33 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApolipoproteins E _xdeficiency |
650 | 0 | 4 | _aCHO Cells |
650 | 0 | 4 |
_aCaveolae _xdrug effects |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aCentrifugation, Density Gradient |
650 | 0 | 4 |
_aCholesterol _xpharmacology |
650 | 0 | 4 | _aCricetinae |
650 | 0 | 4 | _aCricetulus |
650 | 0 | 4 | _aDiet |
650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aIodine Radioisotopes |
650 | 0 | 4 |
_aLipoproteins _xpharmacology |
650 | 0 | 4 |
_aLovastatin _xpharmacology |
650 | 0 | 4 |
_aMembrane Microdomains _xdrug effects |
650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
650 | 0 | 4 |
_aProtein Binding _xdrug effects |
650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xmetabolism |
650 | 0 | 4 | _aReceptor, Transforming Growth Factor-beta Type I |
650 | 0 | 4 | _aReceptor, Transforming Growth Factor-beta Type II |
650 | 0 | 4 |
_aReceptors, Transforming Growth Factor beta _xmetabolism |
650 | 0 | 4 |
_aSmad2 Protein _xmetabolism |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTransforming Growth Factor beta _xpharmacology |
700 | 1 | _aHuang, Shuan Shian | |
700 | 1 | _aHuang, Jung San | |
773 | 0 |
_tJournal of cellular physiology _gvol. 215 _gno. 1 _gp. 223-33 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/jcp.21303 _zAvailable from publisher's website |
999 |
_c17490869 _d17490869 |